Literature DB >> 14979478

Acute spontaneous tumor lysis in anaplastic large T-cell lymphoma presenting with hyperuricemic acute renal failure.

Hsiang-Hao Hsu1, Chiu-Ching Huang.   

Abstract

Acute spontaneous tumor lysis (ASTL) syndrome, an extremely rare disease, requires prompt recognition and aggressive management because it is fulminant at its outset, associated with severe metabolic derangement, and potentially reversible. We describe an unusual case in which spontaneous tumor lysis occurred in anaplastic large T-cell lymphoma associated with acute uric acid nephropathy, persistent oliguria, and shock. This case contrasts markedly with previously reported cases of ASTL syndrome, which developed mainly in the pathologic type of Burkitt lymphoma. To our knowledge, this is the first reported occurrence of ASTL syndrome associated with anaplastic large T-cell type lymphoma. This report also chronicles our successful experience with continuous renal replacement therapy in the presence of compromised hemodynamic status.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14979478     DOI: 10.1007/bf02983533

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.

Authors:  R Förster; A Schubel; D Breitfeld; E Kremmer; I Renner-Müller; E Wolf; M Lipp
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

Review 2.  The current status of lymphoma classification.

Authors:  P G Isaacson
Journal:  Br J Haematol       Date:  2000-05       Impact factor: 6.998

3.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

4.  Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation.

Authors:  W W Agace; A I Roberts; L Wu; C Greineder; E C Ebert; C M Parker
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

5.  Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13.

Authors:  M Nagira; T Imai; K Hieshima; J Kusuda; M Ridanpää; S Takagi; M Nishimura; M Kakizaki; H Nomiyama; O Yoshie
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

6.  Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7.

Authors:  R Yoshida; T Imai; K Hieshima; J Kusuda; M Baba; M Kitaura; M Nishimura; M Kakizaki; H Nomiyama; O Yoshie
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

7.  Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center.

Authors:  J Gale; P D Simmonds; G M Mead; J W Sweetenham; D H Wright
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

8.  The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.

Authors:  Kathleen J Till; Ke Lin; Mirko Zuzel; John C Cawley
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

9.  Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.

Authors:  H Hasegawa; T Nomura; M Kohno; N Tateishi; Y Suzuki; N Maeda; R Fujisawa; O Yoshie; S Fujita
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

10.  Peripheral T-cell lymphomas of the intestine.

Authors:  A Chott; B Dragosics; T Radaszkiewicz
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

View more
  7 in total

1.  Spontaneous tumour lysis syndrome associated with contrast dye iohexol use in mantle cell lymphoma.

Authors:  Seongseok Yun; Nicole D Vincelette; Tuan Phan; Faiz Anwer
Journal:  BMJ Case Rep       Date:  2014-07-15

2.  Spontaneous tumor lysis syndrome with resolution of pancytopenia and disappearance of lymphadenopathy in a patient with peripheral T cell lymphoma unspecified.

Authors:  Sang-Gon Park; Choon-Hae Chung; Chi-Young Park
Journal:  Int J Hematol       Date:  2011-02-24       Impact factor: 2.490

3.  Tumor lysis syndrome and malignant melanoma.

Authors:  Meir Mouallem; Noa Zemer-Wassercug; Eitan Kugler; Nadav Sahar; Ronnie Shapira-Frommer; Ginette Schiby
Journal:  Med Oncol       Date:  2013-05-15       Impact factor: 3.064

4.  Acute renal failure and type B lactic acidosis as first manifestation of extranodal T-cell lymphoblastic lymphoma.

Authors:  Seongseok Yun; Courtney N Walker; Nicole D Vincelette; Faiz Anwer
Journal:  BMJ Case Rep       Date:  2014-06-09

5.  A Rare Case of Spontaneous Tumor Lysis Syndrome in Idiopathic Primary Myelofibrosis.

Authors:  Yong Sub Na; Sang-Gon Park
Journal:  Am J Case Rep       Date:  2019-02-03

6.  Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase).

Authors:  Andrea Pession; Fraia Melchionda; Claudia Castellini
Journal:  Biologics       Date:  2008-03

Review 7.  Tumor lysis syndrome in childhood malignancies.

Authors:  Wing Lum Cheung; Kam Lun Hon; Cheuk Man Fung; Alexander Kc Leung
Journal:  Drugs Context       Date:  2020-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.